Literature DB >> 159710

Local responses in primary and secondary human lung cancers. II. Clinical correlations.

E Kolb, E Müller.   

Abstract

Local infiltrates of eosinophilic leucocytes and macrophages and the deposition of acid mucopolysaccharides (AMPS) in 72 operable primary lung cancers and 17 isolated pulmonary metastases of known origin were correlated to tumour stage (radically or non-radically operable) and clinical course, by following the patients for 2-3 1/2 years. Half of the primary lung cancers showed strong local eosinophilia which, in combination with either strong macrophage infiltration or absence of AMPS reaction, characterized a very good prognosis in radically operable patients. No eosinophils, together with a strong AMPS reaction, indicated a very poor prognosis, irrespective of tumour stage. 16/17 metastases (7 different histologies) had either no local eosinophilia (13), strong AMPS deposition (12) or both (9). This suggests that malignant clones with great metastatic potential in general are characterized by absence of local eosinophilia and/or a strong AMPS reaction. These observations taken together indicate that local eosinophilia expresses an immune reaction which is, houl metastatic clones. It if does, metastatic success may be due to an escape mechanism based on the elaboration of AMPS.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159710      PMCID: PMC2010027          DOI: 10.1038/bjc.1979.196

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  The eosinophil and gastrointestinal carcinoma.

Authors:  I L YOON
Journal:  Am J Surg       Date:  1959-02       Impact factor: 2.565

2.  Macrophage content of tumours in relation to metastatic spread and host immune reaction.

Authors:  S A Eccles; P Alexander
Journal:  Nature       Date:  1974-08-23       Impact factor: 49.962

3.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

4.  Effect of chondroitin sulfate on the growth of solid Ehrlich ascites tumor under the influences of other interstitial components.

Authors:  J Takeuchi
Journal:  Cancer Res       Date:  1968-08       Impact factor: 12.701

5.  Variation in glycosaminoglycan components of breast tumors.

Authors:  J Takeuchi; M Sobue; E Sato; M Shamoto; K Miura
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

6.  Growth-promoting effect of acid mucopolysaccharides on Ehrlich ascites tumor.

Authors:  J Takeuchi
Journal:  Cancer Res       Date:  1966-05       Impact factor: 12.701

7.  Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.

Authors:  E J Goetzl; A H Tashjian; R H Rubin; K F Austen
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Reactive antibodies in the bronchial washings of lung cancer patients.

Authors:  E Paluch; H L Ioachim
Journal:  Int J Cancer       Date:  1979-01-15       Impact factor: 7.396

9.  The immune response at the tumor site in lung carcinoma.

Authors:  H L Ioachim; B H Dorsett; E Paluch
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

10.  Local responses in primary and secondary human lung cancers. I. Patterns of cellular (eosinophils and macrophages) and extracellular (acid mucopolysaccharide) reactions.

Authors:  E Müller; E Kolb
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640

View more
  6 in total

1.  Correlation of eosinophilia with clinical response in patients with advanced carcinoma treated with low-dose recombinant interleukin-2 and mitomycin C.

Authors:  S Arinaga; N Karimine; K Takamuku; S Nanbara; H Inoue; R Abe; D Watanabe; H Matsuoka; H Ueo; T Akiyoshi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells.

Authors:  E Huland; H Huland
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Human eosinophils express transforming growth factor alpha.

Authors:  D T Wong; P F Weller; S J Galli; A Elovic; T H Rand; G T Gallagher; T Chiang; M Y Chou; K Matossian; J McBride
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

4.  Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance.

Authors:  H M Anthony; C J Schorah
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

5.  Blood basophils in lung cancer.

Authors:  H M Anthony
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

6.  Local responses in primary and secondary human lung cancers. I. Patterns of cellular (eosinophils and macrophages) and extracellular (acid mucopolysaccharide) reactions.

Authors:  E Müller; E Kolb
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.